Pancreatic Cancer Research

ResearcherOklahoma City VA Medical CenterNo recent work listed

Naveena B. Janakiram

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6274-1742; OpenAlex author ID A5015292833; NIH RePORTER profile ID 10565411. Sources: OpenAlex.

Their work

Papers
10 (first author 7, last author 1)
Trials
0
Grants
1
Labs led
1
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper, 1 grant · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper

Papers 10

  1. Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention. First author DOI 10.1002/mc.23084↗
  2. Immunoprevention of Pancreatic Cancer. Last author DOI 10.2174/0929867324666170223153509↗
  3. Loss of natural killer T cells promotes pancreatic cancer in LSL-Kras G12D/+ mice. Co-author DOI 10.1111/imm.12746↗
  4. Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. First author DOI 10.18632/oncotarget.22085↗
  5. Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression. First author DOI 10.18632/oncotarget.3499↗
  6. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling. First author DOI 10.1158/1940-6207.capr-14-0176↗
  7. Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling. First author DOI 10.1593/tlo.13556↗
  8. Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice. First author DOI 10.1593/neo.121508↗
  9. Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies. First author DOI 10.2174/092986712801661095↗
  10. Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Co-author DOI 10.1007/s10555-011-9311-2↗

Grants 1

  1. Targeting cancer stem cell initiation during pancreatic cancer development R03CA181584↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Altaf Mohammed · 10 shared papers, 1 shared grant, 2011–2019 · strength 0.78
  2. Chinthalapally V. Rao · 10 shared papers, 2011–2019 · strength 0.56
  3. Gaurav Kumar · 1 shared paper, 2015 · strength 0.04
  4. Hiroshi Y. Yamada · 1 shared paper, 2015 · strength 0.04
  5. Zobeida Cruz‐Monserrate · 1 shared paper, 2015 · strength 0.04
  6. Courtney W. Houchen · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.